Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Pol F. Boudes
Age : 64
Public asset : 33 USD
Linked companies : Galectin Therapeutics Inc. - Protalix Biotherapeutics Inc
Summary 
Presently, Pol F. Boudes occupies the position of Chief Medical Officer at Galectin Therapeutics, Inc. Dr. Boudes is also on the board of Protalix Biotherapeutics, Inc. and Member of American Medical Association, Member of European Association for the Study of the Liver, Member of American Diabetes Association, Member of The Royal Society of Medicine and Member of American Association for The Study of Liver Diseases.

In his past career he held the position of Chief Medical Officer of CymaBay Therapeutics, Inc., Chief Medical Officer for Amicus Therapeutics, Inc., Vice President-Global Clinical Development at Bayer HealthCare Pharmaceuticals, Inc. and Assistant Professor at UniversitÚ Paris 1 PanthÚon-Sorbonne.

Dr. Boudes received a doctorate from UniversitÚ d'Aix-Marseille.


Current positions of Pol F. Boudes 
NameTitle Since
Galectin Therapeutics Inc.
(Biotechnology & Medical Research)
Chief Medical Officer 2020
Protalix Biotherapeutics Inc
(Biotechnology & Medical Research)
Independent Director 2019
American Medical Association Member -
European Association for the Study of the Liver Member -
American Diabetes Association Member -
The Royal Society of Medicine Member -
American Association for The Study of Liver Diseases Member -


Holdings of Pol F. Boudes 
NameEquities%Valuation
Protalix BioTherapeutics, Inc. (PLX)
(Biotechnology & Medical Research)
400.0001%33 USD
Galectin Therapeutics Inc. (GALT)
(Biotechnology & Medical Research)
00.0000%0 USD


Pol F. Boudes: Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/23NELSON PELTZ : Nelson Peltz's Trian builds stake in Unilever - source
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
More news


© 2022 People and Ownership :   
Pol F. Boudes : Connections